{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:22:07Z","timestamp":1790842927623,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T00:00:00Z","timestamp":1260403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T00:00:00Z","timestamp":1260403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/leu.2009.251","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T12:08:46Z","timestamp":1260446926000},"page":"345-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":323,"title":["Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"24","author":[{"given":"K","family":"Schmiegelow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hellebostad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kristinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"S\u00f6derh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Taskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the Nordic Society of Paediatric Haematology and Oncology (NOPHO)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,10]]},"reference":[{"key":"BFleu2009251_CR1","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"CH Pui","year":"2008","unstructured":"Pui CH, Robison LL, Look AT . Acute lymphoblastic leukaemia. Lancet 2008; 371: 1030\u20131043.","journal-title":"Lancet"},{"key":"BFleu2009251_CR2","first-page":"138","volume-title":"Cancer in Children","author":"K Schmiegelow","year":"2005","unstructured":"Schmiegelow K, Gustafsson G . Acute lymphoblastic leukemia. In: Voute PA BASM, Caron M (eds) Cancer in Children, 5th edn Oxford University Press: Oxford, 2005, pp 138\u2013170."},{"key":"BFleu2009251_CR3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1651-2227.1987.tb10565.x","volume":"76","author":"G Gustafsson","year":"1987","unstructured":"Gustafsson G, Garwicz S, Hertz H, Johanesson G, Jonmundsson G, Moe PJ et al. A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results. Acta Paediatr Scand 1987; 76: 781\u2013788.","journal-title":"Acta Paediatr Scand"},{"key":"BFleu2009251_CR4","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/sj.leu.2401961","volume":"14","author":"G Gustafsson","year":"2000","unstructured":"Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia 2000; 14: 2267\u20132275.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR5","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/leu.2008.316","volume":"3","author":"K Schmiegelow","year":"2009","unstructured":"Schmiegelow K, Forestier E, Kristinsson J, Soderhall S, Vettenranta K, Weinshilboum R et al. Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Leukemia 2009; 3: 557\u2013564.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR6","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1200\/JCO.2003.04.039","volume":"21","author":"K Schmiegelow","year":"2003","unstructured":"Schmiegelow K, Bjork O, Glomstein A, Gustafsson G, Keiding N, Kristinsson J et al. Intensification of mercaptopurine\/methotrexate maintenance chemotherapy may increase the risk of relapse for some children with acute lymphoblastic leukemia. J Clin Oncol 2003; 21: 1332\u20131339.","journal-title":"J Clin Oncol"},{"key":"BFleu2009251_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MPH.0b013e3181a6e171","volume":"31","author":"K Schmiegelow","year":"2009","unstructured":"Schmiegelow K, Heyman M, Kristinsson J, Mogensen UB, Rosthoj S, Vettenranta K et al. Oral Methotrexate\/6-Mercaptopurine may be superior to a multi-drug LSA2L2 maintenance therapy for higher risk childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2009; 31: 385\u2013392.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2009251_CR8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/gcc.20517","volume":"47","author":"E Forestier","year":"2008","unstructured":"Forestier E, Gauffin F, Andersen MK, Autio K, Borgstrom G, Golovleva I et al. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Genes Chromosomes Cancer 2008; 47: 149\u2013158.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2009251_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1365-2141.2008.06980.x","volume":"140","author":"E Forestier","year":"2008","unstructured":"Forestier E, Heyman M, Andersen MK, Autio K, Blennow E, Borgstrom G et al. Outcome of ETV6\/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival. Br J Haematol 2008; 140: 665\u2013672.","journal-title":"Br J Haematol"},{"key":"BFleu2009251_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/leu.2008.179","volume":"23","author":"G Lonnerholm","year":"2008","unstructured":"Lonnerholm G, Nordgren A, Frost BM, Jonsson OG, Kanerva J, Nygaard R et al. Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids. Leukemia 2008; 23: 209\u2013212.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/01.mph.0000212972.90877.28","volume":"28","author":"E Forestier","year":"2006","unstructured":"Forestier E, Schmiegelow K . The incidence peaks of the childhood acute leukemias reflect specific cytogenetic aberrations. J Pediatr Hematol Oncol 2006; 28: 486\u2013495.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2009251_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1365-2141.2006.06286.x","volume":"135","author":"K Karrman","year":"2006","unstructured":"Karrman K, Forestier E, Andersen MK, Autio K, Borgstrom G, Heim S et al. High incidence of the ETV6\/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989\u20132005. Br J Haematol 2006; 135: 352\u2013354.","journal-title":"Br J Haematol"},{"key":"BFleu2009251_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.leu.2403540","volume":"19","author":"BM Frost","year":"2005","unstructured":"Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonmundsson G et al. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia 2005; 19: 165\u2013169.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1182\/blood-2007-09-114231","volume":"111","author":"E Forestier","year":"2008","unstructured":"Forestier E, Izraeli S, Beverloo B, Haas O, Pession A, Michalova K et al. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood 2008; 111: 1575\u20131583.","journal-title":"Blood"},{"key":"BFleu2009251_CR15","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/S0301-472X(02)00892-5","volume":"30","author":"AH Li","year":"2002","unstructured":"Li AH, Forestier E, Rosenquist R, Roos G . Minimal residual disease quantification in childhood acute lymphoblastic leukemia by real-time polymerase chain reaction using the SYBR green dye. Exp Hematol 2002; 30: 1170\u20131177.","journal-title":"Exp Hematol"},{"key":"BFleu2009251_CR16","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1182\/blood.V99.4.1253","volume":"99","author":"C Nyvold","year":"2002","unstructured":"Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Svejgaard A, Clausen N et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood 2002; 99: 1253\u20131258.","journal-title":"Blood"},{"key":"BFleu2009251_CR17","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/sj.leu.2403444","volume":"18","author":"M Malec","year":"2004","unstructured":"Malec M, van der Velden VH, Bjorklund E, Wijkhuijs JM, Soderhall S, Mazur J et al. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig\/TcR gene rearrangements and multicolor flow cytometric immunophenotyping. Leukemia 2004; 18: 1630\u20131636.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/sj.leu.2402091","volume":"15","author":"M Malec","year":"2001","unstructured":"Malec M, Bjorklund E, Soderhall S, Mazur J, Sjogren AM, Pisa P et al. Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL. Leukemia 2001; 15: 716\u2013727.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/sj.leu.2402736","volume":"17","author":"E Bjorklund","year":"2003","unstructured":"Bjorklund E, Mazur J, Soderhall S, Porwit-MacDonald A . Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia. Leukemia 2003; 17: 138\u2013148.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0140-6736(07)61126-X","volume":"370","author":"R Pieters","year":"2007","unstructured":"Pieters R, Schrappe M, De LP, Hann I, De RG, Felice M et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007; 370: 240\u2013250.","journal-title":"Lancet"},{"key":"BFleu2009251_CR21","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"F Mitelman","year":"1995","unstructured":"Mitelman F . An International System for Human Cytogenetic Nomenclature. S Karger: Basel, 1995."},{"key":"BFleu2009251_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pbc.10461","volume":"42","author":"UM Saarinen-Pihkala","year":"2004","unstructured":"Saarinen-Pihkala UM, Gustafsson G, Carlsen N, Flaegstad T, Forestier E, Glomstein A et al. Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation. Pediatr Blood Cancer 2004; 42: 8\u201323.","journal-title":"Pediatr Blood Cancer"},{"key":"BFleu2009251_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/(SICI)1096-911X(200005)34:5<319::AID-MPO2>3.0.CO;2-5","volume":"34","author":"UM Saarinen-Pihkala","year":"2000","unstructured":"Saarinen-Pihkala UM, Lanning M, Perkkio M, Makipernaa A, Salmi TT, Hovi L et al. Granulocyte-macrophage colony-stimulating factor support in therapy of high-risk acute lymphoblastic leukemia in children. Med Pediatr Oncol 2000; 34: 319\u2013327.","journal-title":"Med Pediatr Oncol"},{"key":"BFleu2009251_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0140-6736(98)11079-6","volume":"354","author":"MV Relling","year":"1999","unstructured":"Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA et al. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354: 34\u201339.","journal-title":"Lancet"},{"key":"BFleu2009251_CR25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR . Regression models and life-tables (with discussion). J R Stat Soc (B) 1972; 34: 187\u2013220.","journal-title":"J R Stat Soc (B)"},{"key":"BFleu2009251_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4348-9","volume-title":"Statistical Models Based on Counting Processes","author":"PK Andersen","year":"1993","unstructured":"Andersen PK, Borgan \u00d8, Gill RD, Keiding N . Statistical Models Based on Counting Processes. Springer-Verlag: New York, 1993."},{"key":"BFleu2009251_CR27","first-page":"1","volume-title":"Nonparametric Statistics for the Behavioral Sciences","author":"S Siegel","year":"1988","unstructured":"Siegel S, Castellan NJ . Nonparametric Statistics for the Behavioral Sciences, 2nd edn McGraw-Hill Publishing: Singapore, 1988, 1\u2013330."},{"key":"BFleu2009251_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EJ Kaplan","year":"1958","unstructured":"Kaplan EJ, Meier P . Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BFleu2009251_CR29","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1182\/blood-2008-11-187880","volume":"113","author":"K Schmiegelow","year":"2009","unstructured":"Schmiegelow K, Al-Modhwahi I, Andersen MK, Behrendtz M, Forestier E, Hasle H et al. Methotrexate\/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia - results from the NOPHO ALL-92 study. Blood 2009; 113: 6077\u20136084.","journal-title":"Blood"},{"key":"BFleu2009251_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia [see comments]. J Clin Oncol 1996; 14: 18\u201324.","journal-title":"J Clin Oncol"},{"key":"BFleu2009251_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","volume":"9","author":"CH Pui","year":"2008","unstructured":"Pui CH, Howard SC . Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol 2008; 9: 257\u2013268.","journal-title":"Lancet Oncol"},{"key":"BFleu2009251_CR32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/MPH.0b013e318041f112","volume":"29","author":"M Benesch","year":"2007","unstructured":"Benesch M, Sovinz P, Krammer B, Lackner H, Mann G, Schwinger W et al. Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis. J Pediatr Hematol Oncol 2007; 29: 222\u2013226.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2009251_CR33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/nature05690","volume":"446","author":"CG Mullighan","year":"2007","unstructured":"Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758\u2013764.","journal-title":"Nature"},{"key":"BFleu2009251_CR34","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","volume":"110","author":"JB Nachman","year":"2007","unstructured":"Nachman JB, Heerema NA, Sather H, Camitta B, Forestier E, Harrison CJ et al. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia. Blood 2007; 110: 1112\u20131115.","journal-title":"Blood"},{"key":"BFleu2009251_CR35","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","volume":"359","author":"CH Pui","year":"2002","unstructured":"Pui CH, Gaynon PS, Boyett JM, Chessells JM, Baruchel A, Kamps W et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909\u20131915.","journal-title":"Lancet"},{"key":"BFleu2009251_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.bmt.1705914","volume":"41","author":"PA Mehta","year":"2008","unstructured":"Mehta PA, Davies SM . Allogeneic transplantation for childhood ALL. Bone Marrow Transplant 2008; 41: 133\u2013139.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2009251_CR37","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/sj.leu.2402144","volume":"15","author":"K Schmiegelow","year":"2001","unstructured":"Schmiegelow K, Nyvold C, Seyfarth J, Pieters R, Madsen HO, Knabe N et al. Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in-vitro prednisolone resistance. Leukemia 2001; 15: 1066\u20131071.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR38","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.seminhematol.2008.09.001","volume":"46","author":"D Campana","year":"2009","unstructured":"Campana D . Minimal residual disease in acute lymphoblastic leukemia. Semin Hematol 2009; 46: 100\u2013106.","journal-title":"Semin Hematol"},{"key":"BFleu2009251_CR39","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.293.12.1485","volume":"293","author":"M Stanulla","year":"2005","unstructured":"Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. JAMA 2005; 293: 1485\u20131489.","journal-title":"JAMA"},{"key":"BFleu2009251_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/MPH.0b013e3181868570","volume":"30","author":"ML Davidsen","year":"2008","unstructured":"Davidsen ML, Dalhoff K, Schmiegelow K . Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2008; 30: 831\u2013849.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFleu2009251_CR41","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/sj.leu.2402990","volume":"17","author":"U Nygaard","year":"2003","unstructured":"Nygaard U, Schmiegelow K . Dose reduction of coadministered 6-mercaptopurine decreases myelotoxicity following high-dose methotrexate in childhood leukemia. Leukemia 2003; 17: 1344\u20131348.","journal-title":"Leukemia"},{"key":"BFleu2009251_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1056\/NEJM199802193380803","volume":"338","author":"WE Evans","year":"1998","unstructured":"Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH . Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 1998; 338: 499\u2013505.","journal-title":"N Engl J Med"},{"key":"BFleu2009251_CR43","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/cncr.22189","volume":"107","author":"H Hallbook","year":"2006","unstructured":"Hallbook H, Gustafsson G, Smedmyr B, Soderhall S, Heyman M . Treatment outcome in young adults and children &gt;10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer 2006; 107: 1551\u20131561.","journal-title":"Cancer"},{"key":"BFleu2009251_CR44","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1182\/blood-2006-08-040436","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BE, Kinsey SE et al. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Blood 2007; 109: 2327\u20132330.","journal-title":"Blood"}],"updated-by":[{"DOI":"10.1038\/leu.2010.10","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000}}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009251","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009251.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:14:21Z","timestamp":1739474061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,10]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BFleu2009251"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.251","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/leu.2010.10","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,10]]},"assertion":[{"value":"31 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}